Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2 (RFUSIN2-AML1)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2008 by King's College Hospital NHS Trust.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Department of Health
Leukemia Research Fund
Elimination of Leukaemia Fund
Information provided by:
King's College Hospital NHS Trust
ClinicalTrials.gov Identifier:
NCT00718250
First received: June 6, 2008
Last updated: July 16, 2008
Last verified: July 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2012
  Estimated Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)